Inhibiting sorting nexin 10 promotes mucosal healing through SREBP2-mediated stemness restoration of intestinal stem cells
Science Advances · 2023-09 · 9 (35)
DOI: 10.1126/sciadv.adh5016 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2023-09. Verfasst von Weilian Bao und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and the Key Laboratory of Smart Drug Delivery Ministry of Education, School of Pharmacy, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases, Sorting Nexins. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Intestinal stem cell (ISC) is a promising therapeutic target for inflammatory bowel disease. Cholesterol availability is critical for ISC stemness. Low plasma cholesterol is a typical feature of Crohn’s disease (CD); however, its impact on mucosal healing remains unclear. Here, we identified an essential role of sorting nexin 10 (SNX10) in maintaining the stemness of ISCs. SNX10 expression in intestinal tissues positively correlates with the severity of human CD and mouse colitis. Conditional SNX10 knockout in intestinal epithelial cells or ISCs promotes intestinal mucosal repair by maintaining the ISC population associated with increased intracellular cholesterol synthesis. Disassociation of ERLIN2 with SCAP by SNX10 deletion enhances the activation of SREBP2, resulting in increased cholesterol biosynthesis. DC-SX029, a small-molecule inhibitor of SNX10, was used to verify the druggable potential of SNX10 for the treatment of patients with CD. Our study provides a strategy for mucosal healing through SREBP2-mediated stemness restoration of ISCs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and the Key Laboratory of Smart Drug Delivery Ministry of Education, School of Pharmacy, Fudan University, Shanghai, China.
- Department of Natural Medicine, School of Pharmacy, Fudan University, Shanghai, China.
- Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
- Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
- School of Biomedical Sciences, University of Western Australia, Perth, WA, Australia.
- Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.
ORCID-Profile: Weilian Bao, Yan You, Jiahui Ni, Hui Hou, Jiaren Lyu, Keyuan You, Sulin Zhang, Lijie Zhang, Xinyue Cao, Xu Wang, Haidong Li, Hong Li, Jiake Xu, Chenying Liu, Xiaomin Luo, Peng Du, Daofeng Chen, Xiaoyan Shen
Zitieren
APA
Bao, W., You, Y., Ni, J., Hou, H., Lyu, J., Feng, G., Wang, Y., You, K., Zhang, S., Zhang, L., Cao, X., Wang, X., Li, H., Li, H., Xu, J., Liu, C., Luo, X., Du, P., Chen, D., & Shen, X. (2023). Inhibiting sorting nexin 10 promotes mucosal healing through SREBP2-mediated stemness restoration of intestinal stem cells. Science Advances, 9(35). https://doi.org/10.1126/sciadv.adh5016
Vancouver
Bao W, You Y, Ni J, Hou H, Lyu J, Feng G, et al. Inhibiting sorting nexin 10 promotes mucosal healing through SREBP2-mediated stemness restoration of intestinal stem cells. Science Advances. 2023;9(35). doi:10.1126/sciadv.adh5016
BibTeX
@article{Bao2023,
author = {Bao, Weilian and You, Yan and Ni, Jiahui and Hou, Hui and Lyu, Jiaren and Feng, Guize and Wang, Yirui and You, Keyuan and Zhang, Sulin and Zhang, Lijie and Cao, Xinyue and Wang, Xu and Li, Haidong and Li, Hong and Xu, Jiake and Liu, Chenying and Luo, Xiaomin and Du, Peng and Chen, Daofeng and Shen, Xiaoyan},
title = {Inhibiting sorting nexin 10 promotes mucosal healing through SREBP2-mediated stemness restoration of intestinal stem cells},
journal = {Science Advances},
year = {2023},
volume = {9},
number = {35},
doi = {10.1126/sciadv.adh5016}
}
EUVIMED